WallStreetZenWallStreetZen

NYSE: DBD
Diebold Nixdorf Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Diebold Nixdorf revenue was $3.69B for the trailing 12 months ending Sep 30, 2025, with 13,800% growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $945.2M, up 3.3% from last quarter.

DBD past revenue growth

How has DBD's revenue growth performed historically?

Company
-2.86%
Industry
56.75%
Market
20.49%
DBD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DBD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

DBD revenue history

Current Revenue
$3.7B
Current Earnings
$50.6M
Current Profit Margin
1.4%

Be the first to know when DBD announces revenue.

DBD Revenue History By Year

DBD Yearly RevenueDBD RevenueDBD ChangeDBD Revenue Growth
2024-12-31$3.75BN/AN/A

1 of 1

Diebold Nixdorf Revenue FAQ

What was DBD's revenue last quarter?

On Invalid Date, Diebold Nixdorf (NYSE: DBD) reported Q3 2025 revenue of $945.20 million up 1.95% year over year. In the same quarter last year, Diebold Nixdorf's revenue was $927.10 million.

What was Diebold Nixdorf's annual revenue growth in the past year?

As of Q4 2025, Diebold Nixdorf's revenue has grown -2.86% year over year. This is 59.61 percentage points lower than the US Software - Application industry revenue growth rate of 56.75%. Diebold Nixdorf's revenue in the past year totaled $3.69 billion.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.